NicOx SA COX Financial and Strategic SWOT Analysis Review [Report Updated: 09032018] Prices from USD $300

14:37 EDT 14 Mar 2018 | BioPortfolio Reports


NicOx SA NicOx is an pharmaceutical company that develops ophthalmic portfolio of therapies and diagnostic tools. The company offers ophthalmic products which include AdenoPlus, AzaSite, BromSite, Xailin, Vesneo, next generation NOdonors and Syk and JAK inhibitors, and others. It offers products in the therapeutic areas of NOdonating compounds, based on a strong research platform which creates new molecular entities. NicOx operates research centers in Italy that works on RD studies covering various therapy areas such as cardiovascular, inflammation and ophthalmology. The company operates in Germany, the UK, France, Italy and the US. NicOx is headquartered in Nice, France.

NicOx SA Key Recent Developments

Mar 06,2018: Nicox provides 2018 Outlook and 2017 Estimated Financial Results

Jan 03,2018: Nicox Appoints Tomas Navratil, Ph.D., as Head of Development

Dec 19,2017: Nicox Recaps 2017 Achievements, Provides Update on Commercial Availability of VYZULTA and Outlines 2018 Activities

Nov 03,2017: Nicox Highlights VYZULTA approval, Latest Corporate and Financial Developments, and Upcoming Pipeline Initiatives

Oct 24,2017: Nicox Provides Third Quarter 2017 Business Update and Cash Position

This comprehensive SWOT profile of NicOx SA provides you an indepth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of NicOx SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. excluding weekends.

The profile contains critical company information including*,

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Original Article: NicOx SA COX Financial and Strategic SWOT Analysis Review [Report Updated: 09032018] Prices from USD $300


More From BioPortfolio on "NicOx SA COX Financial and Strategic SWOT Analysis Review [Report Updated: 09032018] Prices from USD $300"

Quick Search


Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...